Clinical trials for breast cancer
78 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial

Phase 3
Breast cancer
#NCT04961996
HER2 Negative
HR Positive
Localized
Clinique de l'Europe d'Amiens (Amiens), Hôpital Saint Louis AP-HP (Paris)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT06195709
HER2 Negative
HR Positive
Metastatic
1
Targeted therapy
Hormone therapy
Chemotherapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Léon Bérard (Lyon), Institut du cancer de Montpellier (Montpellier), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Institut Paoli-Calmettes (Marseille), Centre Eugene Marquis (Rennes) (and 1 more...)
Institut Curie
Phase 3
Breast cancer
#NCT06611891
HER2 Negative
HR Positive
Metastatic
1
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Grenoble (La Tronche)
Phase 3
Breast cancer
#NCT04158362
HER2 Negative
HR Positive
Metastatic
Systemic Treatment-Naive
Chemotherapy
Hormone therapy
Hôpital privé Paul D'Egine - Ramsay Santé (Champigny-sur-Marne)
UNICANCER
Phase 3
Breast cancer
#NCT05232916
HER2 Positive
Localized
Locally Advanced
Other mutation
None
Targeted therapy
Targeted therapy
Systemic Treatment-Naive
Systemic Treatment-Naive
Hôpital NOVO (Site de Pontoise) (Pontoise), Centre François Baclesse (Caen ), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Institut Godinot (Reims), CHP Brest - Pasteur Vivalto Santé (Brest) (and 10 more...)
Greenwich LifeSciences, Inc.
Phase 3
Breast cancer
#NCT06393374
HER2 Negative
HR Negative
Localized
Locally Advanced
None
Surgery
Immunotherapy
Chemotherapy
Surgery
Immunotherapy
Chemotherapy
BRCA 1/2
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Franco Britannique (Levallois-Perret), Centre Jean Perrin (Clermont Ferrand ), Centre Henri Becquerel (Rouen ), Centre Hospitalier de la Côte Basque (Bayonne) (and 13 more...)
Merck Sharp & Dohme LLC
Phase 3
Breast cancer
#NCT06112379
HER2 Negative
HR Negative
Locally Advanced
None
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Radiotherapy
Hormone therapy
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Institut du cancer de Montpellier (Montpellier), CHU Caen Normandie (Caen), CHU Reims (Reims) (and 6 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT06018337
HER2 Low
HR Positive
Locally Advanced
Metastatic
1
2
Targeted therapy
Hormone therapy
Chemotherapy
Antibody Drug Conjugates (ADC)
Hôpital Henri-Mondor AP-HP (Créteil), Institut de cancérologie du Gard (Nîmes), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire Angers (Angers ) (and 12 more...)
DualityBio Inc.
Phase 3
Breast cancer
#NCT05952557
HER2 Negative
HR Positive
Localized
None
Surgery
Chemotherapy
Radiotherapy
Hormone therapy
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Jean Perrin (Clermont Ferrand ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 16 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT05894239
HER2 Positive
Locally Advanced
Metastatic
PIK3CA
None
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Polyclinique Bordeaux Nord Aquitaine (Bordeaux)
Hoffmann-La Roche